GRAM Partners with Johnson & Johnson on Manufacturing in Fight Against COVID-19
Grand River Aseptic Manufacturing (“GRAM”), a leading injectable contract development and manufacturing organization (CDMO), has entered into an agreement with…
GRAM selects Stevanato for automated visual inspection equipment
GRAM has developed strategic partnerships to bring flexible solutions to our clients, equipping our facilities with top-of-the-line systems and industry-leading…
Grand River Aseptic Manufacturing Ranked on the Inc. 5000 List for Fourth Consecutive Year
Grand River Aseptic Manufacturing (“GRAM”), a leading parenteral contract development and manufacturing organization (CDMO), was recognized in Inc. Magazine’s Inc….
Federal Government Selects Grand River Aseptic Manufacturing to Help Combat COVID-19
HHS and Dept. of Defense call upon the U.S.-based CDMO to expand domestic fill/finish capacity under Operation Warp Speed …
Nimble Design Philosophy Enabled Aggressive Timeline to Dramatically Increase Capacity
GRAM Expansion ‘puts Grand Rapids on the map’
Written by Rachel Watson, Senior Reporter, with the Grand Rapids Business Journal. See the article here. The phenomenal growth…
Exclusive Interview: Michigan CDMO Scales Up to Meet U.S. Demand
Exclusive interview with Fierce Pharma discussing our new, large-scale fill-finish facility in Grand Rapids, Michigan. With calls for American-made drugs…
GRAM Celebrates New Facility with Ribbon Cutting Ceremony
Earlier this week, Grand River Aseptic Manufacturing (“GRAM”) marked the grand opening of its newest fill/finish facility with a ribbon cutting…
Grand Opening: Large-Scale Injectable Fill/Finish Facility
Grand River Aseptic Manufacturing Opens Large-Scale Injectable Fill/Finish Facility, Significantly Increasing Capacity U.S.-based CDMO completes aggressive expansion plan to serve…